FDA Recall Open, Classified

ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option (approved under P160031).

Recall: Z-2219-2025 · Initiated June 11, 2025

Recall

Recall Number
Z-2219-2025
Event Number
97063
Firm
FUJIFILM Healthcare Americas Corporation
FEI Number
1000513161
Product Code
OTE
Status
Open, Classified
Root Cause
Process control
Initiated
June 11, 2025
Posted
July 30, 2025
Address
81 Hartwell Ave, Ste 300, Lexington, MA, 02421-3160

Description

ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option (approved under P160031).

Reason

Devices had an unapproved slabbing software function enabled for use.

Action

An URGENT: MEDICAL DEVICE RECALL FIRST NOTICE, dated 6/10/25, was sent to consignees. Consignees are to post the notification on/near affected devices and return the completed response form to coordinate a field service engineer to visit. Fujifilm will be sending a Fujifilm healthcare engineer to inspect affected systems and correct the settings to ensure the slabbing feature is inactive. Customers with any questions can contact Fujifilm Customer Service at 1-888-385-4633 or Fujifilm's Field Action Coordinator, Jay Wigley, at [email protected]. Functional/upgrade questions can be directed to the Technical Assistance Center at 1-888-385-4622.

Distribution

Worldwide distribution - US Nationwide and the countries of Canada, Chile, Ecuador.

Quantity

293 units